RO7875913

· Genentech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RO7875913, covering 2026-03-30 to 2026-03-30. Get the full timeline:

Most recent: Clinical Trial Update: A Dose-Escalation Study of RO7875913 in Healthy Participants [Phase 1]